Does VEDOLIZUMAB Cause Peripheral swelling? 986 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 986 reports of Peripheral swelling have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 1.3% of all adverse event reports for VEDOLIZUMAB.
986
Reports of Peripheral swelling with VEDOLIZUMAB
1.3%
of all VEDOLIZUMAB reports
327
Deaths
485
Hospitalizations
How Dangerous Is Peripheral swelling From VEDOLIZUMAB?
Of the 986 reports, 327 (33.2%) resulted in death, 485 (49.2%) required hospitalization, and 251 (25.5%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 986 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which VEDOLIZUMAB Alternatives Have Lower Peripheral swelling Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB